-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TL719dg+JOlINYvqTHiLDpn/1g9Hcsm8VSTSE66c9xdVls7mtk3BuWPRyTnbwiXg E27yv4BwP7pyHaiMk01z0g== 0001140361-07-017427.txt : 20070829 0001140361-07-017427.hdr.sgml : 20070829 20070829125259 ACCESSION NUMBER: 0001140361-07-017427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070829 FILED AS OF DATE: 20070829 DATE AS OF CHANGE: 20070829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DOR BIOPHARMA INC CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 305-534-3383 MAIL ADDRESS: STREET 1: 1101 BRICKELL AVENUE STREET 2: SUITE 701 S CITY: MIAMI STATE: FL ZIP: 33131 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MYRIANTHOPOULOS EVAN CENTRAL INDEX KEY: 0001050955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16929 FILM NUMBER: 071086565 BUSINESS ADDRESS: STREET 1: DISCOVERY LABORATORIES INC STREET 2: 509 MADISON AVE 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2122234504 MAIL ADDRESS: STREET 2: 509 MADISON AVE 14TH FL CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc1.xml FORM 4 X0202 4 2007-08-29 0 0000812796 DOR BIOPHARMA INC DORB 0001050955 MYRIANTHOPOULOS EVAN 1101 BRICKELL AVENUE SUITE 701-S MIAMI FL 33131 1 1 0 0 Chief Financial Officer Common Stock 2007-08-29 4 P 0 70000 0.3096 A 224780 D /s/ Evan Myrianthopoulos 2007-08-29 -----END PRIVACY-ENHANCED MESSAGE-----